We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Multiplex Molecular Tests Detect Seven Intestinal Parasites

By LabMedica International staff writers
Posted on 28 Mar 2011
Polymerase chain reaction (PCR) assays for intestinal parasites can be used on fecal DNA samples for enhanced detection of pathogenic organisms.

A multiplex PCR-based assay for the ova and parasite stool examination is now available and the molecular technology is comparable with microscopy and copro-antigen detection systems. More...


Scientists at the University of Virginia (Charlottesville, VA, USA), adapted several existing real time PCR assays into a high throughput protocol for the major intestinal parasites. Fecal DNA specimens were obtained from 192 preschool-age or younger children from Bangladesh and 190 DNA specimens were obtained from the Leiden University Medical Center (Leiden, Netherlands). Positive control materials were included in this study. The assay involves two multiplex PCR reactions, one with specific primers for the protozoa and one with specific primers for the helminths, after which PCR products are hybridized to beads linked to internal oligonucleotide probes and detected on a Luminex platform (Luminex Corporation, Austin, TX, USA).

The Luminex protozoa assay showed a low limit of detection of 1,000 Giardia lamblia cysts, 100 Cryptosporidium parvum oocysts, and 10 Entamoeba histolytica trophozoites in 200 mg of a stool specimen. The Luminex helminth assay could detect Ancylostoma duodenale, Ascaris lumbricoides, Necator americanus, and Strongyloides stericoralis in very low concentrations. When compared with the parent multiplex real-time PCR assays, this multiplex PCR-bead assay afforded between 83% and 100% sensitivity and specificity on 319 clinical specimens.

The authors concluded that the multiplex PCR-bead protocol provides an alternative high throughput molecular diagnostic platform for specific and sensitive detection of several major intestinal parasites and is a potential alternative to microscopy for equipped laboratories. The study was published in February 2011, in the American Journal of Tropical Medicine and Hygiene.

Related Links:
University of Virginia
Leiden University Medical Center
Luminex Corporation



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more

Immunology

view channel
Image: Study design for analysis of monocyte phenotype, function, and metabolism (Gráinne Jameson et al., Journal of Infection (2026). DOI: 10.1016/j.jinf.2026.106755)

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response

Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.